Ruth Bader Ginsburg announces she is undergoing chemotherapy for a 'reoccurrence of cancer,' can still perform Supreme Court duties
Ginsburg said she would still be able to "do the job full steam" and would continue her "daily active routine."
Following another recent heath scare, Supreme Court Justice Ruth Bader Ginsburg announced Friday that she was undergoing chemotherapy to treat a "reoccurrence of cancer."
Ginsburg, 87, has survived cancer four times before.
On Wednesday she was released from the hospital after getting treatment for an infection stemming from an operation on a tumor on her pancreas.
"On May 19, I began a course of chemotherapy (gemcitabine) to treat a recurrence of cancer," Ginsburg said in the statement. "A periodic scan in February followed by a biopsy revealed lesions on my liver. My recent hospitalizations to remove gall stones and treat an infection were unrelated to this recurrence."
But Ginsburg said the development did not mean she would be stepping down from the bench.
"I am tolerating chemotherapy well and am encouraged by the success of my current treatment," Ginsburg's statement said. "I will continue bi-weekly chemotherapy to keep my cancer at bay, and am able to maintain an active daily routine. Throughout, I have kept up with opinion writing and all other Court work."
"I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that," she added.
In May, Ginsburg was hospitalized for that gallbladder condition, raising concerns about her ability to stay on the bench. She still conducted oral arguments and court business from the hospital.
Beyond being treated for the tumor on her pancreas last year, she was previously treated for colorectal cancer in 1999 and pancreatic cancer in 2009. She had lung surgery to remove cancerous growths in December 2018.
Ginsburg, 87, has survived cancer four times before.
On Wednesday she was released from the hospital after getting treatment for an infection stemming from an operation on a tumor on her pancreas.
"On May 19, I began a course of chemotherapy (gemcitabine) to treat a recurrence of cancer," Ginsburg said in the statement. "A periodic scan in February followed by a biopsy revealed lesions on my liver. My recent hospitalizations to remove gall stones and treat an infection were unrelated to this recurrence."
But Ginsburg said the development did not mean she would be stepping down from the bench.
"I am tolerating chemotherapy well and am encouraged by the success of my current treatment," Ginsburg's statement said. "I will continue bi-weekly chemotherapy to keep my cancer at bay, and am able to maintain an active daily routine. Throughout, I have kept up with opinion writing and all other Court work."
"I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that," she added.
In May, Ginsburg was hospitalized for that gallbladder condition, raising concerns about her ability to stay on the bench. She still conducted oral arguments and court business from the hospital.
Beyond being treated for the tumor on her pancreas last year, she was previously treated for colorectal cancer in 1999 and pancreatic cancer in 2009. She had lung surgery to remove cancerous growths in December 2018.
AI Disclaimer: An advanced artificial intelligence (AI) system generated the content of this page on its own. This innovative technology conducts extensive research from a variety of reliable sources, performs rigorous fact-checking and verification, cleans up and balances biased or manipulated content, and presents a minimal factual summary that is just enough yet essential for you to function as an informed and educated citizen. Please keep in mind, however, that this system is an evolving technology, and as a result, the article may contain accidental inaccuracies or errors. We urge you to help us improve our site by reporting any inaccuracies you find using the "Contact Us" link at the bottom of this page. Your helpful feedback helps us improve our system and deliver more precise content. When you find an article of interest here, please look for the full and extensive coverage of this topic in traditional news sources, as they are written by professional journalists that we try to support, not replace. We appreciate your understanding and assistance.
